WuXi Biologics (Cayman) Inc. (WXIBF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    WuXi Biologics (Cayman) I...

    OTC: WXIBF · Real-Time Price · USD
    5.61
    0.25 (4.66%)
    At close: Oct 03, 2025, 1:09 PM
    5.36
    -4.39%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    WuXi Biologics (Cayman) Income Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 9.95B 10.1B 8.57B 8.54B 8.49B 8.06B 7.21B 5.88B 4.41B
    Cost of Revenue
    		 5.7B 5.8B 5.22B 5.27B 4.93B 4.75B 3.79B 3.35B 2.11B
    Gross Profit
    		 4.25B 4.3B 3.35B 3.27B 3.56B 3.31B 3.41B 2.53B 2.3B
    Operating Income
    		 2.72B 3.15B 1.82B 1.65B 2.3B 1.87B 2.48B 1.53B 1.64B
    Interest Income
    		 n/a 350.37M n/a 64.67M 3.98M 21.75M 34.73M 16.46M 6.51M
    Pretax Income
    		 3.33B 2.83B 2.01B 1.64B 2.53B 2.43B 2.93B 1.93B 2.06B
    Net Income
    		 2.34B 1.86B 1.5B 1.13B 2.27B 1.89B 2.54B 1.55B 1.84B
    Selling & General & Admin
    		 1.19B 1.11B 1.19B 1.17B 915.69M 1.04B 651.78M 599.13M 533.82M
    Research & Development
    		 343.51M 422.38M 344.06M 451.14M 341.44M 418.44M 271.13M 392.46M 115.38M
    Other Expenses
    		 n/a -388.32M n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 1.53B 1.15B 1.53B 1.62B 1.03B 904.92M 512.73M 610.59M 244.02M
    Interest Expense
    		 n/a 157.59M n/a n/a n/a 93.89M 557.83M 11.33M 231.23M
    Selling & Marketing Expenses
    		 270.11M 250.54M 223.06M 188.62M 105.39M 95.81M 67.1M 64.29M 60.36M
    Cost & Expenses
    		 7.23B 6.95B 6.75B 6.9B 5.96B 5.66B 4.31B 3.96B 2.35B
    Income Tax Expense
    		 571.49M 660.96M 228.07M 412.06M 191.12M 498.95M 308.91M 309.09M 175.45M
    Shares Outstanding (Basic)
    		 4.24B 4.08B 4.3B 4.49B 4.36B 4.39B 4.37B 4.42B 4.39B
    Shares Outstanding (Diluted)
    		 4.19B 4.23B 4.26B 4.35B 4.35B 4.37B 4.39B 4.44B 4.41B
    EPS (Basic)
    		 0.58 0.46 0.35 0.26 0.52 0.42 0.58 0.36 0.42
    EPS (Diluted)
    		 0.55 0.43 0.35 0.26 0.52 0.44 0.58 0.34 0.42
    EBITDA
    		 3.45B 3.96B 2.47B 2.13B 2.85B 2.17B 2.9B 1.7B 1.93B
    EBIT
    		 2.72B 3.17B 1.82B 1.63B 2.3B 1.87B 2.48B 1.53B 1.64B
    Depreciation & Amortization
    		 724.81M 783.73M 653.32M 497.73M 359.31M 300.5M 418.13M 167.44M 284.8M

    Add to Watchlist